EpiQAL: Benchmarking Large Language Models in Epidemiological Question Answering for Enhanced Alignment and Reasoning
By: Mingyang Wei , Dehai Min , Zewen Liu and more
Potential Business Impact:
Helps doctors understand how diseases spread.
Reliable epidemiological reasoning requires synthesizing study evidence to infer disease burden, transmission dynamics, and intervention effects at the population level. Existing medical question answering benchmarks primarily emphasize clinical knowledge or patient-level reasoning, yet few systematically evaluate evidence-grounded epidemiological inference. We present EpiQAL, the first diagnostic benchmark for epidemiological question answering across diverse diseases, comprising three subsets built from open-access literature. The subsets respectively evaluate text-grounded factual recall, multi-step inference linking document evidence with epidemiological principles, and conclusion reconstruction with the Discussion section withheld. Construction combines expert-designed taxonomy guidance, multi-model verification, and retrieval-based difficulty control. Experiments on ten open models reveal that current LLMs show limited performance on epidemiological reasoning, with multi-step inference posing the greatest challenge. Model rankings shift across subsets, and scale alone does not predict success. Chain-of-Thought prompting benefits multi-step inference but yields mixed results elsewhere. EpiQAL provides fine-grained diagnostic signals for evidence grounding, inferential reasoning, and conclusion reconstruction.
Similar Papers
Grounded Multilingual Medical Reasoning for Question Answering with Large Language Models
Computation and Language
Helps doctors answer medical questions in many languages.
Harnessing Collective Intelligence of LLMs for Robust Biomedical QA: A Multi-Model Approach
Computation and Language
Helps doctors find answers in medical books faster.
A Specialized Large Language Model for Clinical Reasoning and Diagnosis in Rare Diseases
Computation and Language
Helps doctors find rare diseases faster.